• CHO 4BGD: Quad-Knockout Design and Cell-Fitness Findings

  2026-09-02

  The reference study presents CHO 4BGD, a genome-engineered production host combining disruption of apoptosis and metabolic-selection genes with overexpression of BCL-2 and Beclin-1. Genomic validation, apoptosis-resistance testing, dhfr-based selection, and extended fed-batch experiments indicate that this design can support durable antibody-producing cell lines while illustrating the opportunities and constraints of multiplex CHO engineering.

• Sulfo-Cy3 Azide for Neurogenetic Mapping

  2026-09-02

  Sulfo-Cy3 azide links aqueous Click Chemistry fluorescent labeling with a translational strategy for mapping developmental neurogenetic gradients. This thought-leadership article examines the mechanistic value of a sulfonated bioconjugation reagent, interprets rat claustrum findings, and outlines validation principles, competitive considerations, and realistic paths toward more reproducible neurobiological imaging.

• LDH Cytotoxicity Assay Kit for Nanocompatibility

  2026-09-02

  Use LDH release to compare magnetite–cellulose nanocrystals, hyperthermia conditions, and treatment-related membrane injury without radioactive tracers. This practical workflow combines normalization, interference controls, and reference-study insights for more reliable cell cytotoxicity measurement.

• Tailored CAR Macrophages for Peritoneal Cancer

  2026-09-01

  Gu et al. developed a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal cavity and systematically compared 36 CAR formats. The lead CD3ζ–TLR4 intracellular-domain design promoted inflammatory macrophage activity, reshaped the tumor microenvironment, and enhanced the response to PD-1/L1 therapy through effects on antigen presentation and T-cell states.

• GANT61 Workflows for GLI-Driven Cancer Research

  2026-08-31

  GANT61 provides a practical way to interrogate GLI1/2-dependent transcription at the distal Hedgehog pathway node, from tumor-cell assays to immune-microenvironment studies. This guide combines dose-setting, mechanistic validation, translational assay design, and troubleshooting for cancer research involving tumor growth and immunotherapy resistance.

• YM-155 Hydrochloride Assay Workflow

  2026-08-31

  Build more informative survivin inhibitor experiments by separating growth suppression from actual cell killing. This workflow uses YM-155 hydrochloride with time-resolved viability, death, and model-selection strategies for stronger apoptosis inhibitor research and translational interpretation.

• DiscoveryProbe Protease Inhibitor Library Workflow

  2026-08-30

  Build mechanism-aware biochemical, cell-based, and imaging screens with 825 pre-dissolved protease inhibitors. This workflow adapts a plant stomatal-movement screening strategy into practical assay tiers for protease activity modulation, apoptosis assay development, cancer research, and infectious disease research.

• Biomimetic Chromatography for Lung Permeability

  2026-08-29

  This 2025 study compares immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography coupled with mass spectrometry for modelling pulmonary drug permeability. Its results show that IAM-LC provides a robust partitioning-related predictor, while OT-CEC-MS adds complementary information about phospholipid composition and ion-specific membrane interactions.

• Cholesterol B1702 for Reliable Cell Assays

  2026-08-28

  Learn how Cholesterol (SKU B1702) can improve the interpretation and reproducibility of membrane, viability, proliferation, and lipid nanoparticle workflows. This scenario-based guide covers solubility, storage, assay controls, data interpretation, and practical product-selection criteria.

• Procainamide Hydrochloride in Translational Assays

  2026-08-28

  Procainamide Hydrochloride supports distinct but connected workflows in cardiac electrophysiology, macrophage phenotyping, and DNA methylation research. This guide shows how to separate acute Nav1.5 channel effects from slower immunomodulatory or epigenetic readouts while improving dosing, controls, and troubleshooting.

• Probenecid Workflows for MDR and Neuroprotection

  2026-08-28

  Probenecid is a versatile research tool for testing transporter-driven drug resistance, pannexin-1 biology, and preclinical neuroprotection. This workflow connects concentration-controlled assays with metabolic and inflammatory readouts while keeping mechanistic interpretation and cross-domain limitations explicit.

• Dual Luciferase Reporter Gene System Workflow

  2026-08-27

  Translate lncRNA–FSHR biology into a controlled reporter workflow for promoter activity, pathway-responsive transcription, and normalization in BMSCs. This practical guide combines assay design, high-throughput execution, and troubleshooting for more reliable gene expression regulation studies.

• Hexa His Tag Peptide: Competitive Precision

  2026-08-27

  Competitive elution is more than a downstream convenience: it can determine whether a His-tagged protein interaction experiment yields interpretable biology or antibody-derived background. This thought-leadership perspective connects the reversible binding logic highlighted in recent CARMIL research with practical strategy for using the Hexa His tag peptide in translational protein purification and interaction workflows.

• Leonurine Rewires Doxorubicin Cardiotoxicity

  2026-08-26

  This 2026 Advanced Science study identifies cardiac vascular endothelial cells as early sensors and amplifiers of doxorubicin-induced cardiomyopathy, linking endothelial STING activation to NLRP3 pyroptosis, pathogenic extracellular vesicles, and cardiomyocyte mitochondrial injury. It also presents leonurine as a direct STING inhibitor that binds TYR261, suggesting an endothelial-first therapeutic strategy rather than a cardiomyocyte-only approach.

• Losmapimod and the Next Logic of p38 Control

  2026-08-26

  Losmapimod, also known as GW856553X, is more than a conventional p38 MAPK research tool. Its established anti-inflammatory and vascular biology profile, combined with emerging insight into kinase conformation and dephosphorylation, creates a strategic framework for translational inflammation, hypertension, and COPD research.

454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page